Cancer Vaccine Breakthrough: A Promising New Era for Treatment?
The recent announcement of positive results from a late stage trial of Moderna and Merck's experimental personalized cancer vaccine has sent shockwaves through the medical community, with stock prices soaring as a result.
The initial excitement is understandable, but it's essential to take a step back and consider the broader implications of this breakthrough.